3'-Epi Empagliflozin
| Product Name | 3'-Epi Empagliflozin |
|---|---|
| Alternate Names | Empagliflozin Impurities, Impurities of Empagliflozin |
| CAT No. | CS-O-12062 |
| CAS No. | 864070-43-9 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 450.91 g/mol |
| Mol. For. | C₂₃H₂₇ClO₇ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Empagliflozin |
| Purity | >98% |
| Therapeutic | Anti-Diabetic |
| Smileys | O[C@H]([C@H]1O)[C@@H](O[C@H](CO)[C@H]1O)C2=CC(CC3=CC=C(O[C@@H]4CCOC4)C=C3)=C(Cl)C=C2 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
3'-Epi Empagliflozin is a chemical compound that belongs to the class of SGLT2 inhibitors. The chemical formula of 3'-Epi Empagliflozin is C23H27ClO7 and its molecular weight is 458.91 g/mol. This compound is used in the treatment of type 2 diabetes mellitus. It works by inhibiting the glucose reabsorption in the kidneys, which results in the excretion of excess glucose in the urine.
3'-Epi Empagliflozin is a derivative of Empagliflozin, which is a well-known SGLT2 inhibitor. The modification of the Empagliflozin molecule at the 3'-position results in the formation of 3'-Epi Empagliflozin. This modification increases the potency and selectivity of the compound towards SGLT2 receptors.
The recommended dosage of 3'-Epi Empagliflozin is 10 mg once daily, which can be increased to 25 mg once daily if needed. This compound is usually administered orally and can be taken with or without food. It is important to note that 3'-Epi Empagliflozin should not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis.
In conclusion, 3'-Epi Empagliflozin is a potent and selective SGLT2 inhibitor that is used in the treatment of type 2 diabetes mellitus. Its chemical modification at the 3'-position enhances its therapeutic efficacy and selectivity towards SGLT2 receptors. Proper dosage and administration of 3'-Epi Empagliflozin can help in the management of blood glucose levels in diabetic patients.
Get an Instant Quote
Related Compounds
Empagliflozin Methoxy Intermediate | Empagliflozin MonoAcetyl Impurity | Empagliflozin R-Furanose | Empagliflozin Destetrahydrofuran Impurity | Empagliflozin Sugar Dimer | Empagliflozin Bromo Impurity | DIMETHOXY EMPAGLIFLOZIN | Empagliflozin Silyl Impurity | Empagliflozin Impurity 52 | Empagliflozin Des bromomethoxy | Empagliflozin impurity C | Empagliflozin Dimer Impurity | Empagliflozin S-Furanose | Empagliflozin Impurity 46 | O-Destetrahydrofuran O-Pentaacetyl Empagliflozin | Empagliflozin Enantiomer Impurity | Empagliflozin Impurity 2 | Methoxy Empagliflozin R-Furanose | Empagliflozin Methyl Acetate | Empagliflozin Impurity 62 | Empagliflozin Open Ring Impurity | Empagliflozin Intermediate-A | Empagliflozin L- Glucono Diastereomer | Empagliflozin Diol impurity (S-Isomer) | Empagliflozin Nosyl ester hydroxy furan impurity | Empagliflozin Impurity E | Empagliflozin Methoxy impurity | Empagliflozin M468 | Empagliflozin Dichloro impurity | Empagliflozin impurity B | Empagliflozin Enantiomer Impurity | Empagliflozin M464 | Hydroxy empagliflozin | Empagliflozin Iodo impurity | Empagliflozin Sulfonate Impurity | Empagliflozin Impurity 26 | Empagliflozin impurity A | Empagliflozin Nosyl impurity | Empagliflozin Impurity 50 | Empagliflozin Impurity 4 | Empagliflozin Impurity 82 | Empagliflozin Impurity 40 | Empagliflozin impurity D | Empagliflozin Impurity POE | Empagliflozin alpha Isomer | Empagliflozin Impurity II | Empagliflozin Iodo R-furan impurity | Empagliflozin Impurity 5 | Empagliflozin Acetyl impurity | Empagliflozin Recemic mixture |